Core Insights - The core message of the news is that the company, Plant Doctor, is committed to a long-term strategy as it prepares for its IPO, emphasizing the importance of offline retail, scientific research, and cultural integration in building a sustainable brand [1][7]. Group 1: Offline Retail Strategy - As of June 2025, Plant Doctor has established 4,269 offline stores, focusing on core domestic markets and expanding into Japan, Thailand, and Indonesia, highlighting the significance of in-person consumer experiences in building deep brand relationships [3]. - The company's offline store system is described as a moat, integrating product, service, and social interaction, allowing consumers to not only purchase products but also engage in professional care services and community events [3]. - Plant Doctor ranked second in the beauty and body care sector of the "Top 100 Chain Enterprises in the Service Industry" for two consecutive years from 2022 to 2023, and its omnichannel retail revenue was the highest among single-brand cosmetics stores in 2024 [3]. Group 2: Research and Development - The company has established a comprehensive research and development system in collaboration with the Kunming Institute of Botany, which includes five R&D bases in Beijing, Shunde, and Tokyo, creating a closed-loop system from plant research to formula validation [4]. - Plant Doctor has achieved significant breakthroughs in product formulation, such as the development of bioactive oligosaccharides from Dendrobium, which won a national award for commercial technological advancement [4]. - As of October 2025, the company holds 223 patents, including 68 invention patents, reflecting its commitment to continuous innovation and scientific research in product development [5]. Group 3: Cultural Integration - The brand's philosophy is deeply rooted in the wisdom of the Naxi people, emphasizing a blend of Eastern plant knowledge and modern biotechnology, which is reflected in its complete supply chain from raw material cultivation to efficacy validation [6]. - Plant Doctor has received the Euromonitor certification as a leading single-brand skincare store for three consecutive years, with over 4,000 global stores serving more than 30 million members, showcasing its ability to resonate across cultural differences [6]. - The company's approach to branding emphasizes a long-term commitment to building trust and value, contrasting with the fast-paced trends in the market, and aims to establish a solid foundation for global expansion [7].

Core Viewpoint - The company, Beijing Plant Doctor Cosmetics Co., Ltd., is preparing for its IPO, aiming to become the first single-brand beauty stock in A-shares, despite facing significant challenges and complaints regarding its products and sales practices [2][5][21]. Company Overview - Founded by Jie Yong in 1994, the company transitioned from a brand agent to a retailer, launching its official brand "Plant Doctor" in 2014 with a focus on natural plant extracts [6][8]. - The brand has achieved significant recognition in the domestic market, becoming a leading single-brand beauty company [2]. Financial Performance - The company distributed a total of 180 million yuan in cash dividends in 2024 and 2025, which is approximately equal to half of its net profit for 2024 [5][21]. - Despite the cash distribution, the company has faced stagnant revenue growth, with a compound annual growth rate of only 0.92% from 2022 to 2024 [20]. Market Position and Strategy - The company has primarily focused on offline sales, with over 70% of its revenue coming from offline channels as of 2024, and a significant portion from franchise stores [9][12]. - The brand has expanded rapidly in lower-tier cities, leveraging lower operational costs and a zero-threshold franchise policy [9][12]. Challenges and Complaints - The company has faced numerous complaints regarding product efficacy, aggressive sales tactics, and poor customer service, leading to a negative consumer perception [4][14][17]. - The number of franchise stores decreased for the first time in 2024, indicating potential issues in maintaining its franchise model [12][13]. Industry Context - The Chinese cosmetics market is experiencing a shift towards e-commerce, with online sales accounting for 47% of the market by 2024, contrasting with the company's reliance on offline sales [11][22]. - The competitive landscape is intensifying, with leading brands investing heavily in research and development, while the company has lagged in R&D investment, spending only 3.08% of its revenue on R&D in 2024 [18][20]. Future Outlook - The company is attempting to adapt to changing consumer preferences by entering the instant retail market and developing its online shopping platform, although results are yet to be seen [20][21]. - The ongoing challenges highlight the need for improved compliance management and innovation to sustain growth in a highly competitive market [21].